An ARV-825-loading substance P (SP) peptide-modified polymeric micelles promoted ARV-825 movement across the blood-brain barrier and displayed outstanding anti-proliferative effects against glioma [219], opening an avenue for glioma therapy harnessing TPD technology. This evidence concerns the gene TAC1 and central nervous system cancer.